4-year experience with percutaneous US-guided radiofrequency ablation of kidney tumors

Polish Journal of Radiology

Volumn 72, Issue 2, 2007, Pages 32-35

  Salagierska Barwińska, Anna ^a,b   Salagierski, Marek ^a,b   Salagierski, Maciej ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b Memorial Copernicus Hospital in Lodz   (Poland)

Author keywords

Minimally invasive technique; Radiofrequency ablation; Renal tumor

Indexed keywords

CREATININE; UREA;

ADRENAL METASTASIS; ADULT; AGED; ANURIA; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CREATININE BLOOD LEVEL; DIAGNOSTIC IMAGING; ECHOGRAPHY; FEVER; FOLLOW UP; HERPES ZOSTER; HUMAN; HUMAN TISSUE; HYPERKALEMIA; KIDNEY TUMOR; MAJOR CLINICAL STUDY; NEEDLE BIOPSY; NEURALGIA; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; RADIODIAGNOSTIC EQUIPMENT AND SUPPLIES; RADIOFREQUENCY ABLATION; RENAL REPLACEMENT THERAPY; SURGICAL RISK; UREA BLOOD LEVEL; UREMIA;

EID: 34250612269     PISSN: 1733134X     EISSN: 18990967     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Sheth S, Fishman EK. Multi-detector row CT of the kidneys and urinary tract: techniques and applications in the diagnosis of benign diseases. Radiographics. 2004 Mar-Apr; 24(2): e20.
2. Mouraviev V, Joniau S, Van Poppel H, Polascik TJ. Current status of minimally invasive ablative techniques in the treatment of small renal tumours. Eur Urol. 2007 Feb; 51(2): 328-36.
3. Gervais DA, McGovern FJ, Arellano RS, McDougal WS, Mueller PR. Radiofrequency ablation of renal cell carcinoma: part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. AJR Am J Roentgenol. 2005 Jul; 185(1): 64-71.
4. Arzola J, Baughman SM, Hernandez J, Bishoff JT. Computed tomography-guided, resistance-based, percutaneous radiofrequency ablation of renal malignancies under conscious sedation at two years of follow-up. Urology. 2006 Nov; 68(5): 983-7.
5. Park S, Anderson JK, Matsumoto ED, Lotan Y, Josephs S, Cadeddu JA. Radiofrequency ablation of renal tumors: intermediate-term results. J Endourol. 2006 Aug; 20(8): 569-73.
6. Link RE, Permpongkosol S, Gupta A, Jarrett TW, Solomon SB, Kavoussi LR. Cost analysis of open, laparoscopic, and percutaneous treatment options for nephron-sparing surgery. J Endourol. 2006 Oct; 20(10): 782-9.
7. Gervais DA, Arellano RS, McGovern FJ, McDougal WS, Mueller PR. Radiofrequency ablation of renal cell carcinoma: part 2, Lessons learned with ablation of 100 tumors. AJR Am J Roentgenol. 2005 Jul; 185(1): 72-80.
8. Weizer AZ, Raj GV, O'Connell M, Robertson CN, Nelson RC, Polascik TJ. Complications after percutaneous radiofrequency ablation of renal tumors. Urology. 2005 Dec; 66(6): 1176-80.
9. Pavlovich CP, Walther MM, Choyke PL, Pautler SE, Chang R, Linehan WM, et al. Percutaneous radio frequency ablation of small renal tumors: initial results. J Urol. 2002 Jan; 167(1): 10-5.
10. Permpongkosol S, Link RE, Solomon SB, Kavoussi LR. Results of computerized tomography guided percutaneous ablation of renal masses with nondiagnostic pre-ablation pathological findings. J Urol. 2006 Aug; 176(2): 463-7.
11. Rehman J, Landman J, Lee D, Venkatesh R, Bostwick DG, Sundaram C, Clayman RV. Needle-based ablation of renal parenchyma using microwave, cryoablation, impedance- and temperature-based monopolar and bipolar radiofrequency, and liquid and gel chemoablation: laboratory studies and review of the literature. J Endourol. 2004 Feb; 18(1): 83-104. Review.
12. Tacke J, Mahnken AH, Gunther RW. Percutaneous thermal ablation of renal neoplasms. Rofo. 2005 Dec; 177(12): 1631-40. Review.
13. Anderson JK, Shingleton WB, Cadeddu JA. Imaging associated with percutaneous and intraoperative management of renal tumors. Urol Clin North Am. 2006 Aug; 33(3): 339-52. Review.
14. Svatek RS, Sims R, Anderson JK, Abdel-Aziz K, Cadeddu JA. Magnetic resonance imaging characteristics of renal tumors after radiofrequency ablation. Urology. 2006 Mar; 67(3): 508-12.
15. Rendon RA, Kachura JR, Sweet JM, Gertner MR, Sherar MD, Robinette M, et al.: The uncertainty of radio frequency treatment of renal cell carcinoma: findings at immediate and delayed nephrectomy. J Urol. 2002 Apr; 167(4): 1587-92.
16. Matlaga BR, Zagoria RJ, Woodruff RD, Torti FM, Hall MC. Phase II trial of radio frequency ablation of renal cancer: evaluation of the kill zone. J Urol. 2002 Dec; 168(6): 2401-5.
17. Jinzaki M, McTavish JD, Zou KH, Judy PF, Silverman SG. Evaluation of small (
18. Beer AJ, Dobritz M, Zantl N, Weirich G, Stollfuss J, Rummeny EJ. Comparison of 16-MDCT and MRI for characterization of kidney lesions. AJR Am J Roentgenol. 2006 Jun; 186(6): 1639-50.
19. Catalano C, Fraioli F, Laghi A et al. High-resolution multidetector CT in the preoperative evaluation of patients with renal cell carcinoma. AJR Am J Roentgenol. 2003 May; 180(5): 1271-7.
20. Kalinka A, Gerlach A, Arlart IP et al. Characterization and staging of renal tumors: significance of MRI diagnostics. Rofo. 2006 Mar; 178(3): 298-305.
21. Boss A, Martirosian P, Schraml C, et al. Morphological, contrast-enhanced and spin labeling perfusion imaging for monitoring of relapse after RF ablation of renal cell carcinomas. Eur Radiol. 2006 Jun; 16(6): 1226-36.
22. Thomsen HS. Nephrogenic systemic fibrosis: A serious late adverse reaction to gadodiamide. Eur Radiol. 2006 Dec; 16(12): 2619-21.